BSE filing, NSE: JENBURPH. Summary written from the filing by ALFA Finder's alert engine.
Jenburkt Pharmaceuticals Ltd: key numbers
- Share price
- ₹866.00
- Market cap
- ₹382.2 Cr
- Revenue (annual)
- ₹168.7 Cr
- Net profit (annual)
- ₹34.74 Cr
- P/E (TTM)
- 11.6×Sector 46.1×
- Promoter holding
- 46.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jenburkt Pharmaceuticals Ltd
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Jenburkt Pharmaceuticals Capital Structure Change
Counter Cyclical Investments Private Limited acquired 326 shares of Jenburkt Pharmaceuticals Ltd in the open market, increasing its total shareholding from 4.99% to 5.01%.
Jenburkt Pharmaceuticals Other Announcement
Jenburkt Pharmaceuticals submitted a certificate under SEBI Regulation 74(5) regarding share dematerialization for the quarter ended September 30, 2026.
Jenburkt Pharmaceuticals Other Announcement
Jenburkt Pharmaceuticals clarified its shares are permitted to trade on NSE without a listing application. The shares remain listed on BSE under the Permitted to Trade category.
Jenburkt Pharmaceuticals Management Change
Mr. Vinay Bhatt, Senior Vice President- International Business, has resigned from Jenburkt Pharmaceuticals Limited effective September 18, 2026, due to personal reasons.
Jenburkt Pharmaceuticals Annual General Meeting
Jenburkt Pharmaceuticals held its 41st Annual General Meeting on 4th September, 2026, to discuss financial statements, dividend declaration, and director appointments.
Other board meeting date announcements
All →Svarnim Trade Udyog Board Meeting Date
Svarnim Trade Udyog will hold a board meeting on 3 November 2026 to consider unaudited quarterly and half-year results. No amounts are stated.
Intrasoft Technologies Board Meeting Date
Intrasoft Technologies will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. Trading window remains closed until 48 hours after the meeting.
Ruparel Food Products Board Meeting Date
Ruparel Food Products will hold a board meeting on 02-Nov-2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window is closed from 01-Oct-2026.
Accedere Board Meeting Date
Accedere Limited intimated a board meeting on 4 November 2026 to consider its unaudited Q2 standalone and consolidated results. Trading window closure is also noted, so this is a future meeting notice.
Systematic Industries Board Meeting Date
Systematic Industries Limited intimates a board meeting on November 3, 2026, to consider unaudited standalone results for the half year ended September 30, 2026. The trading window is closed from October 1, 2026 until 48 hours after the results are declared.
Oceanic Foods Board Meeting Date
Oceanic Foods Limited intimates a board meeting on November 3, 2026, to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a future meeting notice with agenda items only proposed.